Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage dna pk'

Search results for: 'research area dna damage dna pk'

Items 31-40 of 62

Page
per page
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    Target: Topoisomerases
    Summary: inhibitor of topoisomerase I
      ≥23.8 mg/mL
  2. AZD8055
    A8214 AZD8055
     2 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥23.3 mg/mL
  3. Mechlorethamine HCl
    B1785 Mechlorethamine HCl
    Summary: DNA synthesis inhibitor
  4. Gemcitabine
    A8437 Gemcitabine
     1 Citation
    Summary: inhibitor of DNA synthesis
      ≥11.75 mg/mL
  5. PI-103 Hydrochloride
    A3724 PI-103 Hydrochloride
    Target: PI3K|mTOR|DNA-PK
    Summary: DNA-PK/PI 3-kinase/mTOR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.25 mg/mL
  6. AZD7762
    A5919 AZD7762
    Target: Chk
    Summary: Checkpoint kinase inhibitor,ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
  7. MK-8776 (SCH-900776)
    A8477 MK-8776 (SCH-900776)
    Target: Chk
    Summary: Chk1 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥18.8 mg/mL
  8. LY3023414
    B6099 LY3023414
    Target: Akt|PI3K|mTOR|DNA-PK
    Summary: class I PI3K isoforms, mTOR and DNA-PK inhibitor
      ≥40.6 mg/mL
  9. EX 527 (SEN0014196)
    A4181 EX 527 (SEN0014196)
     1 Citation
    Target: Sirtuin
    Summary: SIRT1 inhibitor
      insoluble in H2O; ≥12.43 mg/mL
  10. AZD6482
    A5478 AZD6482
    Target: PI3K
    Summary: PI3Kβ inhibitor,potent and selective
      insoluble in H2O; ≥20.4 mg/mL

Items 31-40 of 62

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 59item
  2. Natural Products 2item
  3. Lab Reagents 1 item
Specificity
  1. Selective 41item
Reversibility
  1. Reversible 2item
Target
  1. Akt 1 item
  2. PI3K 6item
  3. mTOR 4item
  4. AP-1 1 item
  5. Chk 2item
  6. Thymidylate Synthase 1 item
  7. STAT 4item
  8. Estrogen and Related Receptors 1 item
  9. Reverse Transcriptases 1 item
  10. JAK 1 item
  11. DNA-PK 6item
  12. Topoisomerases 9item
  13. DNA Methyltransferases 2item
  14. Ubiquitin-specific proteases 1 item
  15. Fatty-acid-binding proteins (FABPs) 1 item
  16. ATM/ATR 2item
  17. HIV Integrases 1 item
  18. BLM 1 item
  19. HSV 1 item
  20. Synthases/Synthetases 2item
  21. MAGL 1 item
  22. Histamine H1 Receptors 1 item
  23. RNA Polymerases 2item
  24. CMV 1 item
  25. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  26. Cytidine deaminases 1 item
  27. PPAR 1 item
  28. PTK 1 item
  29. prolactin secretion 1 item
  30. gonadotropin release 1 item
  31. benzodiazepine receptor 1 item
  32. TRPC channel 1 item
  33. ATM 1 item
  34. Sirtuin 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 1 item
  3. Acute Renal Failure 1 item
  4. Bladder Cancer 1 item
  5. Bladder Carcinoma 1 item
  6. Bladder Diseases 1 item
  7. Breast Cancer 9item
  8. Cancer 43item
  9. Cervical Cancer 2item
  10. Colon Cancer 7item
  11. Colorectal Cancer 4item
  12. Glioblastoma 3item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 2item
  15. HIV 1 item
  16. HIV Infections 1 item
  17. Inflammatory Diseases 1 item
  18. Leukemia 5item
  19. Lung Cancer 3item
  20. Lymphoma 3item
  21. Melanoma 4item
  22. Multiple Myeloma 1 item
  23. Myeloma 2item
  24. Neuroblastoma 1 item
  25. Non-small Cell Lung Carcinoma 1 item
  26. Ovarian Cancer 6item
  27. Pancreatic Cancer 2item
  28. Prostate Cancer 5item
  29. Sarcoma 1 item
  30. Squamous Cell Carcinoma 1 item
  31. Testicular Cancer 2item
  32. Type 2 Diabetes 1 item